Phase 3 Study of High-Dose Biotin, MD1003, for PPMS & SPMS

A board to discuss future MS therapies in early stage (Phase I or II) trials.

Phase 3 Study of High-Dose Biotin, MD1003, for PPMS & SPMS

Postby seeva » Fri May 19, 2017 7:27 am

HI Friends please read
https://multiplesclerosisnewstoday.com/ ... -patients/

A Phase 3 clinical trial has been launched by MedDay Pharmaceuticals to investigate whether treatment with high-dose biotin (MD1003) may ease disability and improve mobility in non-relapsing primary or secondary progressive MS patients. The study is recruiting participants across the U.S., Canada and Europe.

regards
seeva
User avatar
seeva
Family Elder
 
Posts: 446
Joined: Sun Jan 20, 2008 4:00 pm
Location: SYDNEY

Advertisement

Return to Drug Pipeline

 


  • Related topics
    Replies
    Views
    Last post

Who is online

Users browsing this forum: No registered users


Contact us | Terms of Service